Literature DB >> 2482292

Biochemical and structural studies of tenascin/hexabrachion proteins.

H C Taylor1, V A Lightner, W F Beyer, D McCaslin, G Briscoe, H P Erickson.   

Abstract

Tenascin is a large, disulfide-bonded glycoprotein of the extracellular matrix. The predominant form of tenascin observed by electron microscopy is a six-armed oligomer, termed a hexabrachion. We have determined the molecular mass of the native human hexabrachion to be 1.9 x 10(6) Da by sedimentation equilibrium analysis and by electrophoresis on non-reducing agarose gels. On reducing polyacrylamide gel electrophoresis (SDS-PAGE), human tenascin showed a single prominent band at 320 kDa and minor bands of 220 and 230 kDa. The molecular weight of the native human hexabrachion is thus consistent with a disulfide-bonded hexamer of the 320 kDa subunits. Upon treatment with neuraminidase, the apparent molecular weights of all human and chicken tenascin subunits on reducing SDS-PAGE were decreased by about 10 kDa. Prolonged incubation with alpha-mannosidase, however, caused no apparent change in the apparent molecular weight of tenascin subunits. Sedimentation in a cesium chloride gradient gave a higher buoyant density for human tenascin than for fibronectin, suggesting that it has a higher degree of glycosylation. The far-UV circular dichroism spectrum indicates a predominance of beta-structure and a lack of collagen-like or alpha-helical structure. When human hexabrachions were reduced and acetylated, the resulting fragments were single arms which sedimented at 6 S in glycerol gradients and migrated at 320 kDa on non-reducing gels. Treatment of tenascin with trypsin and alpha-chymotrypsin also produced large fragments which were fractionated by gradient sedimentation and analyzed by non-reducing SDS-PAGE and electron microscopy. We present a structural model for the assembly of the observed fragments into the elaborate native hexabrachion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482292     DOI: 10.1002/jcb.240410204

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Differential expression of genes in cells cultured from juxtacanalicular trabecular meshwork and Schlemm's canal.

Authors:  E Timothy O'Brien; Yanhong Wang; Hongyu Ying; Beatrice Y J T Yue
Journal:  J Ocul Pharmacol Ther       Date:  2014-03-10       Impact factor: 2.671

2.  Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype.

Authors:  U Hedin; J Holm; G K Hansson
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

Review 3.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

4.  Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

Authors:  A M Tokés; S Paku; S Tóth; E Paál; J Kulka; J Tóth; A Telekes
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  The mechanism by which hyperbaric oxygen treatment alleviates spinal cord injury: genome-wide transcriptome analysis.

Authors:  Zhen-Cheng Sun; Fang Liang; Jing Yang; Yong Hai; Qing-Jun Su; Xue-Hua Liu
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

6.  Colocalization of tenascin with versican, a hyaluronate-binding chondroitin sulfate proteoglycan.

Authors:  G Perides; H P Erickson; F Rahemtulla; A Bignami
Journal:  Anat Embryol (Berl)       Date:  1993-11

7.  Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair.

Authors:  B A Wenczak; J B Lynch; L B Nanney
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

8.  Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin.

Authors:  J E Murphy-Ullrich; V A Lightner; I Aukhil; Y Z Yan; H P Erickson; M Höök
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

9.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

10.  The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

Authors:  M S Diamond; J Garcia-Aguilar; J K Bickford; A L Corbi; T A Springer
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.